SAN DIEGO--(BUSINESS WIRE)--Sequenom, Inc. (NASDAQ:SQNM), a leading provider of genetic analysis solutions, today announced the purchase of Sequenom’s MassARRAY® system by the DNA Diagnostic Lab of the McKusick-Nathans Institute of Genetic Medicine and the Translational Technology Core of the Institute for Translational Clinical Research at Johns Hopkins University School of Medicine. Scientists plan to use the system as a platform for genotyping, clinical genotyping, DNA methylation and quantitative gene expression (QGE) analyses.
